Research

New-Onset Refractory Status Epilepticus with Underlying Autoimmune Etiology: a Case Report February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223986/

Learn more
Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003900/

Learn more
Hashimoto’s encephalopathy: Follow-up data from neuropsychology, lumbar puncture, and FDG-PET February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745505/

Learn more
S100A6 Promotes B Lymphocyte Penetration Through the Blood-Brain Barrier in Autoimmune Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901080/

Learn more
Fatigue, Sleep, and Autoimmune and Related Disorders February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691096/

Learn more
Autoimmune encephalitis associated with antibodies against the metabotropic glutamate receptor type 1: case report and review of the literature February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535747/

Learn more
Severe relapse of anti-NMDA receptor encephalitis 5 years after initial symptom onset February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661405/

Learn more
Autoimmune encephalitis with anti-IgLON5 and anti-GABAB-receptor antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531245/

Learn more
Early second-line therapy is associated with improved episodic memory in anti-NMDA receptor encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649545/

Learn more
Immune-Checkpoint-Inhibitor-Induced Severe Autoimmune Encephalitis Treated by Steroid and Intravenous Immunoglobulin February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444136/

Learn more